Registration Information
The conference registration fee is $100 for 6 CEUs including 3.25
pharmacology CEUs. This fee includes a great conference,
breakfast, snacks and lunch. Meeting handouts will be available at
our website prior to the conference.
Register online at https://papnofhouston.starchapter.com
Mind Matters 2015
Psychiatric Issues for
Advanced Practice Nurses
You may also mail a check and registration form (available for printing
on our website): PAPN, P.O. Box 540211, Houston, TX 77254. No
mailed registrations accepted after June 1st.
Please register early, and no later than Friday, June 5th, 2015.
No walk-in registration please, in order to properly plan our venue.
No refunds will be made after June 1st. If circumstances necessitate
the cancellation of this conference, registration fees will be refunded
in full.
Questions
Please check our website for more information. You
may also e-mail us at: PAPNWeb@gmail.com or phone
832-363-7787.
Location
Houston Methodist Hospital
Texas Medical Center
6565 Fannin Street, Houston, TX
77030 (713) 790-3311
Parking is included
Dunn Tower Conference Room in
the Rio Grande
Psychiatric Advanced Practice Nurses of Houston
PO Box 540211 Houston, TX 77254
www.PAPNHouston.org
Saturday, June 6, 2015
Houston Methodist Hospital
PAPN’s Mind Matters 2015: Psychiatric Issues for Advanced Practice Nurses
Agenda
Saturday, June 6, 2015
Target Audience:
5. Analyze the latest information in
This conference is designed for Psychiatric
Advanced Practice Nurses, APRNs and RNs
in other specialties with an interest in
psychiatric evaluation and management.
genetics and other biomarkers
of mental illness.
Accreditation
This activity is being submitted for
approval to AANP for 6 Nursing CE
including 3.25 pharmacology credits.
Conference Goals
Attendees must attend the entire
This program will provide current, evidence- program to receive CEU credit; no
based and clinically useful information to
partial credit.
improve the quality of nursing care
No partial credit will be granted.
provided to patients with psychiatric and
Participants must attend the entire
substance abuse disorders.
program from 8:30 am – 3:00pm to
Conference Objectives
receive CEUs.
Upon completion of this conference
participants will be able to:
1. Discuss psychotropic medications and
indications with recent FDA approval.
2. Recognize risk factors and treatment
of acute substance abuse disorders.
3. Describe the interface of ethics and
psychiatry.
4. Manage multiple manifestations of
psychiatric illness.
8:00am – 9:00 am – Registration &
Continental Breakfast
8:30 - Introductions
8:35am – 9:30 am – Update on
Psychotropic Medications
Kayode Giwa, PharmD,
Psychopharmacologist at Houston
Methodist
9:30am – 10:00am – Genetic Testing in
Psychiatry (non-branded)
Jose Estrada, PhD, Medical Science Liason at
Assurex HealthAssurex Health
10:00am – 10:15am – Break & Visit with
Vendors
10:15am – 11:15am – Psychiatry and Ethics
in the Genomic Era
Sherry Grogan, PMHNP, Transplant
Consult – Liaison Psychiatry, Houston
Methodist
11:15am – 11:45am
Geripsychiatric Care: The Gray Sunami
Dorothy Morrison, PMHNP Acute Care
Psychiatric NP, Houston Methodist
Hospital
11:45 am – 12:15pm – Lunch & Visit with
Vendors
12:15pm – 1:15 pm Substance Abuse Treatment With a
Focus on Safe Detox
Sara Wood, PMHNP
The ParC Substance Abuse Treatment
1:15 am – 1:45am – Psychiatry in an
Acute and Post-Acute Medical/Surgical
Population
Patti Hardesty, Psychiatric CNS, Delivery
System Reform Incentive Payment
(DSRIP) Program, Houston Methodist
1:4 5am – 2:00 pm - Break
2:00pm – 2:30 pm – Benzodiazepines –
The Good, The Bad, & The Ugly
Linda Barloon, PMHNP, Consult-Liaison
Psychiatry, Houston Methodist
“Our expectation . . . is that identifying syndromes based on pathophysiology will eventually be able to improve outcomes.”
2:30pm – 3:30 pm Bipolar Depression
The NIMH is launching the Research Domain Criteria (RDoC) project to create a framework for research on pathophysiology, especially for genomics and neuroscience, which ultimately will inform future DSM classification schemes.
Alric Hawkins, MD, Acute, ER and
Consult-Liaison Psychiatry, Houston
THOMAS INSEL, M.D. BRUCE CUTHBERT, Ph.D., Am J Psychiatry 167:7, July 2010